# The Expression of Serum Angiogenesis Marker in Patients Presenting With Hemoptysis

> **NCT01171768** · — · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 52 (estimated)

## Conditions studied

- Inflammatory Lung Diseases
- Hemoptysis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01171768
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** —
- **Final completion:** 2010-12
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2011-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01171768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01171768, "The Expression of Serum Angiogenesis Marker in Patients Presenting With Hemoptysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01171768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*